
Frédéric BIHEL
112
Documents
Publications
Publications
FORMULATIONS FOR METAL CATALYSIS IN WATER COMPRISING A SURFACTANT AND A LIPOPHILIC COMPOUNDUnited States, Patent n° : US2023191383. 2023
Brevet
hal-04930599
v1
|
|
NOVEL PFAR-INHIBITING COMPOUNDSFrance, Patent n° : 20220273637. 2022
Brevet
hal-04012493
v1
|
|
Utilisation de tensioactifs pour extraire de l'or ou un métal du groupe platine à partir de compositions organiquesFrance, N° de brevet: EP16180529. 2016
Brevet
hal-02120430
v1
|
|
Ornithine- and lysine-derivatives for the treatment of painFrance, Patent n° : EP2669276. 2013
Brevet
hal-04742565
v1
|
Anti-tumor activity of new ligands targeting LINGO1- a protein primarily expressed in CNS for the treatment of glioblastomasColloque Niche et épigénétique des tumeurs, Jul 2020, Online, France
Communication dans un congrès
hal-03686680
v1
|
|
|
Allosteric Modulators of CDK4 for Lung Cancer TherapeuticsAnnual Meeting on Experimental Biology, The Federation of American Societies for Experimental Biology (FASEB), Apr 2020, San Diego (California), United States. pp.1-1, ⟨10.1096/fasebj.2020.34.s1.00334⟩
Communication dans un congrès
hal-04570635
v1
|
The research of new therapeutic targets and small chemical molecules for glioblastoma therapiesCentral South University in HuNan, Dec 2019, Changsha, China
Communication dans un congrès
hal-03686683
v1
|
|
6-Endo-dig cyclization of heteroarylesters to alkynes promoted by Lewis acid catalyst in presence of Brønsted acidSAJEC, Oct 2007, Paris, France
Communication dans un congrès
hal-00195387
v1
|
|
6-Endo-dig cyclization of heteroarylesters to alkynes promoted by Lewis acid catalyst in presence of Brønsted acidXXVII REGIO, Sep 2007, Buhl, France
Communication dans un congrès
hal-00195398
v1
|
|
Synthèse et fonctionnalisation de 2,3-benzodiazépines : Vers la construction d'une chimiothèque focaliséeJournée Scientifique de l'Institut Gilbert Laustriat, Apr 2007, Illkirch, France
Communication dans un congrès
hal-00195391
v1
|
|
Creation of a Chemical Diversity Space Around the 2,3-Benzodiazepine ScaffoldInternational Symposium on Advances in Synthetic and Medicinal Chemistry, Aug 2007, Saint Petersbourg, Russia
Communication dans un congrès
hal-00195383
v1
|
|
Microwave-assisted cyclic amidine synthesis using TiCl4Journée Scientifique de l'IFR Gilbert Laustriat, 2006, Illkirch, France
Communication dans un congrès
hal-00195376
v1
|
|
Design and synthesis of Benzodiazepines as phthalazine structurally-related compounds10th International Symposium on the Chemistry and Pharmacology of Pyridazines, Jun 2006, Strasbourg, France
Communication dans un congrès
hal-00195377
v1
|
|
Synthèse assistée par micro-onde d'amidines cycliques médiée par TiCl4SECO'43, May 2006, Fréjus, France
Communication dans un congrès
hal-00195388
v1
|
|
P2Y1 Purinergic Receptor : Synthesis of a fluorescent ProbeStrep GPCR / Joint Meeting, Feb 2005, Barcelone, Spain
Communication dans un congrès
hal-00195392
v1
|
Evaluation of the anti-tumoral acitivty of new ligands targeting LINGO-1 for the treatment of glioblastomaJournée du cancéropole Grand ouest, Oct 2020, Virtual, France
Poster de conférence
hal-03686678
v1
|
|
Anti-tumor activity of new ligands targeting LINGO1- a protein primarily expressed in CNS for the treatment of glioblastomasColloque Niche et épigénétique des tumeurs, Jul 2020, Online, France.
Poster de conférence
hal-03686675
v1
|
|
Etude de l’activité anti-tumorale de nouveaux ligands ciblant LINGO-1 pour le traitement des glioblastomesJournée Fédération FR2708 Physique et Chimie du Vivant, Apr 2019, Orléans, France
Poster de conférence
hal-03625295
v1
|
|
Etude de l’activité anti-tumorale de nouveaux ligands ciblant LINGO-1 pour le traitement des glioblastomesColloque de l’ADOC, Jul 2019, Orléans, France
Poster de conférence
hal-03686230
v1
|
|
Nouvelles molécules chimiques anti-tumorales pour le traitement du glioblastomes13es journées du Cancéropôle Grand Ouest, Jul 2019, Tours, France
Poster de conférence
hal-02973622
v1
|
|
Anti-tumoral activity of new ligands targeting LINGO-1 for the treatment of glioblastoma1st meeting « Niches and Epigenetic of tumors », Mar 2019, Nantes, France
Poster de conférence
hal-02973567
v1
|
|
In vitro and in vivo characterization of RF313 the first orally available NPFF receptor antagonist.SFN 45th Annual Meeting, Chicago, USA, (2015-10-17 / 2015-10-21), Oct 2015, Chicago, United States. 2015
Poster de conférence
hal-04747309
v1
|
|
Pallado-catalyzed reactions applied to solid phase synthesis of dipeptidic GPR54 agonists18e Congrès du GFPP, Sète, France, (2013-05-26 / 2013-05-31), May 2013, Sète, France. 2013
Poster de conférence
hal-04747272
v1
|
|
Modulation of nociception and morphine analgesia by endogenous RF−amide peptides.Gordon Research Conference on Molecular Pharmacology, Il Ciocco, Italie (2013-05-08 / 2013-05-13), May 2013, Il Ciocco, Italy. 2013
Poster de conférence
hal-04750860
v1
|
|
Development of the first orally available NPFF1-R antagonist capable of reversing opioid-induced hyperalgesia in rodentsInternational conference on Medicinal Chemistry RICT 2012, Poitiers, France, (2012-07-04 /2012-07-06), Jul 2012, Poitiers, France. 2012
Poster de conférence
hal-04754574
v1
|
|
Neuropeptide FF receptors as novel drug targets in epilepsySFN 42nd Annual Meeting, New Orleans, USA, (2012-10-13 / 2012-10-17), Oct 2012, New Orleans, United States. 2012
Poster de conférence
hal-04747273
v1
|
|
Neuropeptide FF decreases Cortical and Amygdala Excitability Via NPFF1 and/or NPFF2 ReceptorsSFN 42nd Annual Meeting, New Orleans, USA, (2012-10-13 / 2012-10-17), Oct 2012, New Orleans, United States. 2012
Poster de conférence
hal-04747286
v1
|
|
Dérivés polysubstitués de pyridines comme ligands hétérocycliques de GPR54Journée jeunes chercheurs SCT, Mar 2012, Romainville, France. 2012
Poster de conférence
hal-05035740
v1
|
Chargement...
Chargement...